ונקומיצין מיילן 500 מג

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

지금 구매하세요

유효 성분:

VANCOMYCIN AS HYDROCHLORIDE

제공처:

GENMEDIX , ISRAEL

ATC 코드:

A07AA09

약제 형태:

LYOPHILIZED POWDER FOR INJECTION

구성:

VANCOMYCIN AS HYDROCHLORIDE 500 MG/VIAL

관리 경로:

תוך-ורידי, פומי

처방전 유형:

מרשם נדרש

Manufactured by:

MYLAN S.A.S., FRANCE

치료 그룹:

VANCOMYCIN

치료 영역:

VANCOMYCIN

치료 징후:

Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal

승인 날짜:

2011-10-31

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 영어 15-05-2017
제품 특성 요약 제품 특성 요약 영어 20-08-2017
공공 평가 보고서 공공 평가 보고서 영어 17-08-2016